| Authors: |
Wicks AT; Cancer Research UK Scotland Institute Garscube Estate, Switchback Road Glasgow G61 1BD UK d.huang@crukscotlandinstitute.ac.uk.; School of Cancer Sciences, University of Glasgow Glasgow G61 1QH UK., Buetow L; Cancer Research UK Scotland Institute Garscube Estate, Switchback Road Glasgow G61 1BD UK d.huang@crukscotlandinstitute.ac.uk., Suzuki T; Cancer Research UK Scotland Institute Garscube Estate, Switchback Road Glasgow G61 1BD UK d.huang@crukscotlandinstitute.ac.uk., Schmidt T; Cancer Research UK Scotland Institute Garscube Estate, Switchback Road Glasgow G61 1BD UK d.huang@crukscotlandinstitute.ac.uk., Lilla S; Cancer Research UK Scotland Institute Garscube Estate, Switchback Road Glasgow G61 1BD UK d.huang@crukscotlandinstitute.ac.uk., Macmillan-Jones A; AstraZeneca, R&D Biopharmaceuticals, Discovery Sciences, Cellular Assay Development, The Discovery Centre 1 Francis Crick Avenue Cambridge CB2 0AA UK., Turney J; AstraZeneca, R&D Biopharmaceuticals, Discovery Sciences, Protein Sciences, Structure & Biophysics, The Discovery Centre 1 Francis Crick Avenue Cambridge CB2 0AA UK., Gohlke A; AstraZeneca, R&D Biopharmaceuticals, Discovery Sciences, Protein Sciences, Structure & Biophysics, The Discovery Centre 1 Francis Crick Avenue Cambridge CB2 0AA UK., Bushell M; Cancer Research UK Scotland Institute Garscube Estate, Switchback Road Glasgow G61 1BD UK d.huang@crukscotlandinstitute.ac.uk.; School of Cancer Sciences, University of Glasgow Glasgow G61 1QH UK., Hock AK; AstraZeneca, R&D Biopharmaceuticals, Discovery Sciences, Cellular Assay Development, The Discovery Centre 1 Francis Crick Avenue Cambridge CB2 0AA UK., Huang DT; Cancer Research UK Scotland Institute Garscube Estate, Switchback Road Glasgow G61 1BD UK d.huang@crukscotlandinstitute.ac.uk.; School of Cancer Sciences, University of Glasgow Glasgow G61 1QH UK. |